journal article·2017-05Open access

Degradable, absorbable or resorbable—what is the best grammatical modifier for an implant that is eventually absorbed by the body?

Yang Liu, Yufeng Zheng, Byron Hayes

Science China Materials· Volume 60· Issue 5

Abstract

The adoption of grammatical modifier for implants or other kinds of biomaterials eventually absorbed by the body has been a long-standing confusing issue, and there are diverse terms in the large fields of research, which not only causes the difficulties when searching on the Internet, but also blurs the meaning and boundaries for researchers. Prior unification attempts at laws/standards set the basis for such research fields towards researching, labeling, marketing and instructions for use. Considering this, the typical grammatical modifiers “biodegradable”, “resorbable”, “absorbable”, along with their noun forms used in the decades of scientific research have been reviewed and explained, interdisciplinary in chemistry, ecology, materials science, biology, microbiology, medicine, and based on usage customs, laws, standards and markets. The term “biodegradable” has been not only used in biomaterials but also in ecology waste management, biomedicine and even natural environment. Meanwhile, the term “resorbable” has long been used in biological reaction (osteoclast driven bone resorption), but is inappropriate for implants that do not carry the potential to grow back into their original form. The term “absorbable” focuses more on the host metabolism to the foreign biodegradation products of the implanted material/device compared with the term “degradable/biodegradable”. Meanwhile the coherence and normalization of the term “absorbable” carried by its own in laws and standards contributes as well. In general, the authors consider the term “absorbable” to be the best grammatical modifier with respect to other adjectives which share the same inherence. A further internationally unified usage is proposed by us.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Mackenzie D. The history of sutures. Med Hist, 1973, 17: 158–16810.1017/S0025727300018469 ↗
2. Hench LL. Bioceramics. J Am Ceramic Soc, 2005, 81: 1705–172810.1111/j.1151-2916.1998.tb02540.x ↗
3. Hench LL. Bioceramics: fromconcept to clinic. J AmCeramic Soc, 1991, 74: 1487–151010.1111/j.1151-2916.1991.tb07132.x ↗
4. Windhagen H, Radtke K, Weizbauer A, et al. Biodegradable magnesium-based screw clinically equivalent to titanium screw in hallux valgus surgery: short term results of the first prospective, randomized, controlled clinical pilot study. BioMed Eng OnLine, 2013, 12: 6210.1186/1475-925X-12-62 ↗
5. Schildwächter M. Biotronik announces CE mark for magmaris, the first clinically-proven bioresorbable magnesium scaffold. http://www.magmaris.com/en/newsroom/june-15-2016
6. Shalaby SW, Burg KJL. Bioabsorbable polymers update: degradation mechanisms, safety, and application. J App Biomater, 1995, 6: 219–22110.1002/jab.770060313 ↗
7. Vert M, Li SM, Spenlehauer G, et al. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci-Mater Med, 1992, 3: 432–44610.1007/BF00701240 ↗
8. Vert M. Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts. J Mater Sci-Mater Med, 2009, 20: 437–44610.1007/s10856-008-3581-4 ↗
9. Benicewicz BC, Hopper PK. Part I. J Bioactive Compatible Polym, 1990, 5: 453–47210.1177/088391159000500407 ↗
10. Barrows HT. Synthetic bioabsorbable polymers. In: Szycher M (Ed.). High Performance Biomaterials: A Complete Guide toMedical and Pharmceutical Applications. Boca Raton: CRC PRESS, 1991, 243–257
11. Weiler A, Hoffmann RFG, Stähelin AC, et al. Biodegradable implants in sports medicine: the biological base. Arthroscopy-J Arthroscopic Related Surgery, 2000, 16: 305–32110.1016/S0749-8063(00)90055-0 ↗
12. Ikada Y, Tsuji H. Biodegradable polyesters for medical and ecological applications. Macromol Rapid Commun, 2000, 21: 117–13210.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X ↗
13. Ashammakhi N, Peltoniemi H, Waris E, et al. Developments in craniomaxillofacial surgery: use of self-reinforced bioabsorbable osteofixation devices. Plast Reconstr Surg, 2001, 108: 167–18010.1097/00006534-200107000-00027 ↗
14. Vert M, Doi Y, Hellwich KH, et al. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure Appl Chem, 2012, 84: 377–41010.1351/PAC-REC-10-12-04 ↗
15. The United States Pharmacopeial Convention. The Second Supplement to the Pharmacopeia of theUnited States of America: 11th decennial revision (USP XI-1939 Supplement). 1939
16. Truhlsen SM. The recession operation: histopathologic response, and suture reaction and absorption. Trans Am Ophthalmol Soc, 1965, 63: 626–677
17. USP in U.S. Law. http://www.usp.org/print/about-usp/legal-recognition/ usp-us-law
18. USP develops and publishes standards for drug substances, drug products, excipients, and dietary supplements in the United States Pharmacopeia-National Formulary (USP-NF)
19. United States Public Law 94-295. 1976
20. United States Pharmacopeia. http://www.usp.org/
21. British Pharmacopeia. https://www.pharmacopoeia.com/
22. European Pharmacopoeia. http://online.pheur.org/EN/entry.htm
23. Williams DF. TheWilliams Dictionary of Biomaterials. Liverpool: Liverpool University Press, 1999
24. https://en.wikipedia.org/wiki/Biodegradation
25. Jones RG, Kahovec J, Stepto R, et al. Compendium of Polymer Terminology and Nomenclature: IUPAC Recommendations 2008. Cambridge: RSC Publishing, 200910.1039/9781847559425 ↗
26. Higashi S, Yamamuro T, Nakamura T, et al. Polymer-hydroxyapatite composites for biodegradable bone fillers. Biomaterials, 1986, 7: 183–18710.1016/0142-9612(86)90099-2 ↗
27. de Groot K. Bioceramics of Calcium Phosphate. Boca Raton: CRC Press, 198310.1007/978-1-349-07283-5_41 ↗
28. Hollinger JO, Battistone GC. Biodegradable bone repair materials synthetic polymers and ceramics. Clin Orthop Relat Res, 1986, 207: 290–30610.1097/00003086-198606000-00046 ↗
29. ASTMD653-14, Standard Terminology Relating to Soil, Rock, and Contained Fluids. ASTM International, West Conshohocken, PA, 2014. https://www.astm.org/Standards/D653.htm
30. Witte F, Hort N, Vogt C, et al. Degradable biomaterials based on magnesium corrosion. Curr Opin Solid State Mater Sci, 2008, 12: 63–7210.1016/j.cossms.2009.04.001 ↗
31. Lynn DM, Langer R. Degradable poly(ß-amino esters): synthesis, characterization, and self-assemblywith plasmidDNA. JAmChem Soc, 2000, 122: 10761–1076810.1021/ja0015388 ↗
32. Cima LG, Vacanti JP, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng, 1991, 113: 143–15110.1115/1.2891228 ↗
33. Zhang S, Zhang X, Zhao C, et al. Research on an Mg-Zn alloy as a degradable biomaterial. Acta Biomater, 2010, 6: 626–64010.1016/j.actbio.2009.06.028 ↗
34. Anseth KS, Metters AT, Bryant SJ, et al. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release, 2002, 78: 199–20910.1016/S0168-3659(01)00500-4 ↗
35. Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem, 2003, 14: 934–94010.1021/bc034014g ↗
36. ASTM E2747-11, Standard Specification for Evaluation and Selection of Onsite Offices for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/ E2747.htm
37. ASTM E2745-11, Standard Specification for Evaluation and Selection of Audio Visual (AV) and Production for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/E2745.htm
38. ASTM E2746-11, Standard Specification for Evaluation and Selection of Communication and Marketing Materials for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTMInternational,West Conshohocken, PA, 2011. https://www.astm.org/Standards/E2746.htm
39. ASTM E2741-11, Standard Specification for Evaluation and Selection of Destinations for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/ E2741.htm
40. ASTM E2773-11, Standard Specification for Evaluation and Selection of Food and Beverage for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/ E2773.htm
41. ASTM E2742-11, Standard Specification for Evaluation and Selection of Exhibits for Environmentally SustainableMeetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/E2742.htm
42. ASTM E2774-11, Standard Specification for Evaluation and Selection of Venues for Environmentally Sustainable Meetings, Events, Trade Shows, and Conferences. ASTM International, West Conshohocken, PA, 2011. https://www.astm.org/Standards/E2774.htm
43. ASTM F2902-12, Standard Guide for Assessment of Absorbable Polymeric Implants. ASTM International, West Conshohocken, PA, 2012. https://www.astm.org/Standards/F2902.htm
44. https://en.wikipedia.org/wiki/Resorption
45. Venes D. Taber’s Cyclopedic Medical Dictionary, 22th edition. Philadelphia: F. A. Davis Company, 2013
46. Zheng YF, Gu XN, Witte F. Biodegradable metals. Mater Sci Eng- R-Rep, 2014, 77: 1–3410.1016/j.mser.2014.01.001 ↗
47. Hanawa T. Metal ion release from metal implants. Mater Sci Eng-C, 2004, 24: 745–75210.1016/j.msec.2004.08.018 ↗
48. Zreiqat H, Howlett CR, Zannettino A, et al. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res, 2002, 62: 175–18410.1002/jbm.10270 ↗
49. Little PJ, Bhattacharya R, Moreyra AE, et al. Zinc and cardiovascular disease. Nutrition, 2010, 26: 1050–105710.1016/j.nut.2010.03.007 ↗
50. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol, 1998, 50: 375–38210.1111/j.2042-7158.1998.tb06876.x ↗
51. Shikinami Y. Shape-memory, biodegradable and absorbable material. U.S. Patent No. 6,281,262, 2001-8-28
52. Huitema TW, Knight GW, Ransick MH, Schulze DR. Surgical implant with preferential corrosion zone. U.S. Patent No. 7,905,902, 2011-3-15
53. Luzier WD. Materials derived from biomass/biodegradable materials. Proc Natl Acad Sci USA, 1992, 89: 839–84210.1073/pnas.89.3.839 ↗
54. Gross RA, Kalra B. Biodegradable polymers for the environment. Science, 2002, 297: 803–80710.1126/science.297.5582.803 ↗
55. Trumbo P, Schlicker S, Yates AA, et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc, 2002, 102: 1621–163010.1016/S0002-8223(02)90346-9 ↗
56. Chambin O, Champion D, Debray C, et al. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release, 2004, 95: 101–10810.1016/j.jconrel.2003.11.009 ↗
57. Fundueanu G, Constantin M, Esposito E, et al. Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system. Biomaterials, 2005, 26: 4337–434710.1016/j.biomaterials.2004.10.036 ↗
58. Märtson M, Viljanto J, Hurme T, et al. Is cellulose sponge degradable or stable as implantation material? An in vivo subcutaneous study in the rat. Biomaterials, 1999, 20: 1989–199510.1016/S0142-9612(99)00094-0 ↗
59. Patel N, Padera R, Sanders GH, et al. Spatially controlled cell engineering on biodegradable polymer surfaces. The FASEB journal, 1998, 12: 1447–145410.1096/fasebj.12.14.1447 ↗
60. Goldstein A. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials, 2001, 22: 1279–128810.1016/S0142-9612(00)00280-5 ↗
61. Wu L, Ding J. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials, 2004, 25: 5821–583010.1016/j.biomaterials.2004.01.038 ↗
62. Wu L, Ding J. Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. J Biomed Mater Res, 2005, 75A: 767–77710.1002/jbm.a.30487 ↗
63. Pan Z, Ding J. Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine. Interface Focus, 2012, 2: 366–37710.1098/rsfs.2011.0123 ↗
64. Yu L, Zhang Z, Zhang H, et al. Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water. Biomacromolecules, 2010, 11: 2169–217810.1021/bm100549q ↗
65. Wen X, Tresco PA. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels. Biomaterials, 2006, 27: 3800–380910.1016/j.biomaterials.2006.02.036 ↗
66. Chu CFL, Lu A, Liszkowski M, et al. Enhanced growth of animal and human endothelial cells on biodegradable polymers. BBA-Gen Subjects, 1999, 1472: 479–48510.1016/S0304-4165(99)00151-8 ↗
67. Jo S, Engel PS, Mikos AG. Synthesis of poly(ethylene glycol)-tethered poly(propylene fumarate) and its modification with GRGD peptide. Polymer, 2000, 41: 7595–760410.1016/S0032-3861(00)00117-8 ↗
68. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release, 2005, 104: 51–6610.1016/j.jconrel.2005.02.002 ↗
69. Freed LE, Vunjak-Novakovic G, Biron RJ, et al. Biodegradable polymer scaffolds for tissue engineering. Nat Biotechnol, 1994, 12: 689–69310.1038/nbt0794-689 ↗
70. Windecker S, Serruys PW, Wandel S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet, 2008, 372: 1163–117310.1016/S0140-6736(08)61244-1 ↗
71. Stefanini GG, Kalesan B, Serruys PW, et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet, 2011, 378: 1940–194810.1016/S0140-6736(11)61672-3 ↗
72. Raungaard B, Jensen LO, Tilsted HH, et al. Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial. Lancet, 2015, 385: 1527–153510.1016/S0140-6736(14)61794-3 ↗
73. Freed LE, Grande DA, Lingbin Z, et al. Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res, 1994, 28: 891–89910.1002/jbm.820280808 ↗
74. Poirier Y, Nawrath C, Somerville C. Production of polyhydroxyalkanoates, a family of biodegradable plastics and elastomers, in bacteria and plants. Nat Biotechnol, 1995, 13: 142–15010.1038/nbt0295-142 ↗
75. Dias A, Tsuru K, Hayakawa S, et al. Crystallisation studies of biodegradable CaO-P2O5 glass with MgO and TiO2 for bone regeneration applications. Glass Technol, 2004, 45: 78–79
76. Klein CPAT, de Groot K, Drißsen AA, et al. Interaction of biodegradable ß-whitlockite ceramics with bone tissue: an in vivo study. Biomaterials, 1985, 6: 189–19210.1016/0142-9612(85)90008-0 ↗
77. Ikenaga M, Hardouin P, Lemaître J, et al. Biomechanical characterization of a biodegradable calcium phosphate hydraulic cement: a comparison with porous biphasic calcium phosphate ceramics. J Biomed Mater Res, 1998, 40: 139–14410.1002/(SICI)1097-4636(199804)40:1<139::AID-JBM16>3.0.CO;2-J ↗
78. Dias AG, Lopes MA, Santos JD, et al. In vivo performance of biodegradable calcium phosphate glass ceramics using the rabbit model: histological and SEM observation. J Biomater Appl, 2006, 20: 253–26610.1177/0885328206052466 ↗
79. Lee JH, Lee CK, Chang BS, et al. In vivo study of novel biodegradable and osteoconductive CaO-SiO2-B2O3 glass-ceramics. J Biomed Mater Res, 2006, 77A: 362–36910.1002/jbm.a.30594 ↗
80. Song G, Song S. A possible biodegradablemagnesium implantmaterial. Adv Eng Mater, 2007, 9: 298–30210.1002/adem.200600252 ↗
81. Kim WC, Kim JG, Lee JY, et al. Influence of Ca on the corrosion properties of magnesium for biomaterials. Mater Lett, 2008, 62: 4146–414810.1016/j.matlet.2008.06.028 ↗
82. Li Z, Gu X, Lou S, et al. The development of binary Mg-Ca alloys for use as biodegradablematerials within bone. Biomaterials, 2008, 29: 1329–134410.1016/j.biomaterials.2007.12.021 ↗
83. Wan Y, Xiong G, Luo H, et al. Preparation and characterization of a new biomedical magnesium-calcium alloy. Mater Des, 2008, 29: 2034–203710.1016/j.matdes.2008.04.017 ↗
84. Seong JW, Kim WJ. Development of biodegradable Mg-Ca alloy sheets with enhanced strength and corrosion properties through the refinement and uniformdispersion of theMg2Ca phase by highratio differential speed rolling. Acta Biomater, 2015, 11: 531–54210.1016/j.actbio.2014.09.029 ↗
85. Zhang S, Li J, Song Y, et al. In vitro degradation, hemolysis and MC3T3-E1 cell adhesion of biodegradable Mg-Zn alloy. Mater Sci Eng-C, 2009, 29: 1907–191210.1016/j.msec.2009.03.001 ↗
86. Li J, Song Y, Zhang S, et al. In vitro responses of human bone marrow stromal cells to a fluoridated hydroxyapatite coated biodegradable Mg-Zn alloy. Biomaterials, 2010, 31: 5782–578810.1016/j.biomaterials.2010.04.023 ↗
87. Brar HS, Wong J, Manuel MV. Investigation of the mechanical and degradation properties of Mg-Sr and Mg-Zn-Sr alloys for use as potential biodegradable implant materials. J Mech Behav Biomed Mater, 2012, 7: 87–9510.1016/j.jmbbm.2011.07.018 ↗
88. Bornapour M, Muja N, Shum-Tim D, et al. Biocompatibility and biodegradability of Mg-Sr alloys: the formation of Sr-substituted hydroxyapatite. Acta Biomater, 2013, 9: 5319–533010.1016/j.actbio.2012.07.045 ↗
89. Gu XN, Xie XH, Li N, et al. In vitro and in vivo studies on a Mg-Sr binary alloy system developed as a new kind of biodegradable metal. Acta Biomater, 2012, 8: 2360–237410.1016/j.actbio.2012.02.018 ↗
90. Hänzi AC, Gerber I, Schinhammer M, et al. On the in vitro and in vivo degradation performance and biological response of new biodegradableMg-Y-Zn alloys. Acta Biomater, 2010, 6: 1824–183310.1016/j.actbio.2009.10.008 ↗
91. Chou DT, Hong D, Saha P, et al. In vitro and in vivo corrosion, cytocompatibility and mechanical properties of biodegradable Mg-Y-Ca-Zr alloys as implant materials. Acta Biomater, 2013, 9: 8518–853310.1016/j.actbio.2013.06.025 ↗
92. Zong Y, Yuan G, Zhang X, et al. Comparison of biodegradable behaviors of AZ31 and Mg-Nd-Zn-Zr alloys in Hank’s physiological solution. Mater Sci Eng-B, 2012, 177: 395–40110.1016/j.mseb.2011.09.042 ↗
93. Tie D, Feyerabend F, Müller WD, et al. Antibacterial biodegradable Mg-Ag alloys. Eur Cell Mater, 2013, 25: 284–29810.22203/eCM.v025a20 ↗
94. Vojtech D, Kubásek J, Serák J, et al. Mechanical and corrosion prop- erties of newly developed biodegradable Zn-based alloys for bone fixation. Acta Biomater, 2011, 7: 3515–352210.1016/j.actbio.2011.05.008 ↗
95. Li H, Yang H, Zheng Y, et al. Design and characterizations of novel biodegradable ternary Zn-based alloys with IIA nutrient alloying elements Mg, Ca and Sr. Mater Des, 2015, 83: 95–10210.1016/j.matdes.2015.05.089 ↗
96. Liu X, Sun J, Yang Y, et al. Microstructure, mechanical properties, in vitro degradation behavior and hemocompatibility of novel Zn-Mg-Sr alloys as biodegradable metals. Mater Lett, 2016, 162: 242–24510.1016/j.matlet.2015.07.151 ↗
97. Wu C, Qiu H, Hu X, et al. Short-term safety and efficacy of the biodegradable iron stent in mini-swine coronary arteries. Chin Med J (Engl), 2013, 126: 4752–475710.3760/cma.j.issn.0366-6999.20131120 ↗
98. Purnama A, Hermawan H, Champetier S, et al. Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents. Acta Biomater, 2013, 9: 8746–875310.1016/j.actbio.2013.02.033 ↗
99. Hermawan H, Purnama A, DubeD, et al. Fe-Mn alloys formetallic biodegradable stents: degradation and cell viability studies. Acta Biomater, 2010, 6: 1852–186010.1016/j.actbio.2009.11.025 ↗
100. Sheridan MH, Shea LD, Peters MC, et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release, 2000, 64: 91–10210.1016/S0168-3659(99)00138-8 ↗